Anderson Lab

University of Iowa

PHARMACOLOGY

Iowa City · United States

NIH-funded
Rate this labNo reviews yet — be the first.

Research focus

NIH R01 · 2024

Determinants of cardioprotection by circulating prohibitin-1 during sepsis

ABSTRACT: Sepsis is a dangerous hyper-inflammatory condition that carries a mortality rate of 25% for uncomplicated cases and rises to 80% for patients who develop multiple organ dysfunction syndrome (MODS). No specific therapies for MODS exist, which is why identification of druggable targets and biomarkers for diagnosis/prognosis are urgently needed. During the acute phase response in sepsis, circulating factors such as cytokines and endotoxins cause oxidative stress and derangements in mitochondrial morphology and function in the heart, ultimately leading to septic cardiomyopathy (SepCM), a manifestation of MODS. Prohibitins (PHB1,2) are proteins that assemble in hetero-oligomeric…

From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.

Reviews

← All labs at University of Iowa